Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiguang Yang

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Frontiers in Bioengineering and Biotechnology|October 20, 2025
Deep learning on brain metastasis for predicting EGFR genotype and EGFR-TKI therapy response in metastatic NSCLC: a multicenter studyShuailin You, Ying Fan, Zhiguang Yang, et al.
Nuclear Medicine and Biology|December 23, 2014
Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility studyXin Zhang, Jun Xin, Yu Shi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 13, 2021
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysisXuan Chen, Zhiguang Yang, Guiyuan Xiang, et al.
Journal of Cancer|September 21, 2017
Systematic Correlation Analyses of Circulating Tumor Cells with Clinical Variables and Tumor Markers in Lung Cancer PatientsXu Wang, Kewei Ma, Zhiguang Yang, et al.
Scientific Reports|February 19, 2016
Calstabin 2: An important regulator for learning and memory in miceQi Yuan, Ke-Yu Deng, Le Sun, et al.
Nuclear Medicine and Biology|March 23, 2017
<sup>99m</sup>Tc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawnXin Zhang, Qiyong Guo, Yu Shi, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Efficacy of Immunotherapy Combined with Antiangiogenic Therapy in Treatment-Failure Patients with Advanced Carcinoma Ex Pleomorphic Adenoma of the Submandibular Gland: A Case ReportHuanlan Sa, Yinghui Xu, Xiaobo Ma, et al.
Anti-Cancer Drugs|August 22, 2021
Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non-small-cell lung cancer: a case reportYunpeng Liu, Zhiru Gao, Chengbin Zhang, et al.
Immunotherapy|December 19, 2023
Imaging findings can't mean everything in the era of immunotherapy: a case report and literature reviewXiangye Zhao, Kewei Ma, Xiaobo Ma, et al.
Anti-Cancer Drugs|February 15, 2021
Successful treatment of Afatinib plus Apatinib using for a lung adenocarcinoma patient with HER-2 V659D mutation: a rare case reportChao Sun, Yinghui Xu, Xu Wang, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Bioengineering and Biotechnology|October 20, 2025
Deep learning on brain metastasis for predicting EGFR genotype and EGFR-TKI therapy response in metastatic NSCLC: a multicenter studyShuailin You, Ying Fan, Zhiguang Yang, et al.
Nuclear Medicine and Biology|December 23, 2014
Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility studyXin Zhang, Jun Xin, Yu Shi, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 13, 2021
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysisXuan Chen, Zhiguang Yang, Guiyuan Xiang, et al.
Journal of Cancer|September 21, 2017
Systematic Correlation Analyses of Circulating Tumor Cells with Clinical Variables and Tumor Markers in Lung Cancer PatientsXu Wang, Kewei Ma, Zhiguang Yang, et al.
Scientific Reports|February 19, 2016
Calstabin 2: An important regulator for learning and memory in miceQi Yuan, Ke-Yu Deng, Le Sun, et al.
Nuclear Medicine and Biology|March 23, 2017
<sup>99m</sup>Tc-3PRGD2 scintigraphy to stage liver fibrosis and evaluate reversal after fibrotic stimulus withdrawnXin Zhang, Qiyong Guo, Yu Shi, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Efficacy of Immunotherapy Combined with Antiangiogenic Therapy in Treatment-Failure Patients with Advanced Carcinoma Ex Pleomorphic Adenoma of the Submandibular Gland: A Case ReportHuanlan Sa, Yinghui Xu, Xiaobo Ma, et al.
Anti-Cancer Drugs|August 22, 2021
Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non-small-cell lung cancer: a case reportYunpeng Liu, Zhiru Gao, Chengbin Zhang, et al.
Immunotherapy|December 19, 2023
Imaging findings can't mean everything in the era of immunotherapy: a case report and literature reviewXiangye Zhao, Kewei Ma, Xiaobo Ma, et al.
Anti-Cancer Drugs|February 15, 2021
Successful treatment of Afatinib plus Apatinib using for a lung adenocarcinoma patient with HER-2 V659D mutation: a rare case reportChao Sun, Yinghui Xu, Xu Wang, et al.
Pageof 8